Showing results (1261-1270 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|December 16, 2021
Understanding the barriers and enablers of pharmacogenomic testing in primary care: a qualitative systematic review with meta-aggregation synthesisSadaf Qureshi, Asam Latif, Laura Condon, et al.
Pharmacogenomics|December 6, 2021
Polymorphisms of genes related to phase II metabolism and resistance to clopidogrelAbdullah Alkattan, Ahmed Alkhalifah, Eman Alsalameen, et al.
Pharmacogenomics|October 31, 2022
Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliabilityYa-Feng Wen, Pamala A Jacobson, William S Oetting, et al.
Pharmacogenomics|October 4, 2022
Effects of SLCO1B1 on elimination and toxicities of high-dose methotrexate in pediatric acute lymphoblastic leukemiaFei-Fei Yang, Tian-Lin Xue, Chao Gao, et al.
Pharmacogenomics|August 31, 2022
Characterization of POR haplotype distribution in African populations and comparison with other global populationsRoss P Booyse, David Twesigomwe, Scott Hazelhurst
Pharmacogenomics|February 22, 2022
Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancerDeniz Ozberk, Alison Haywood, Heidi G Sutherland, et al.
Pharmacogenomics|April 16, 2019
Genomics of radiation sensitivity in squamous cell carcinomasAnuradha Thiagarajan, N Gopalakrishna Iyer
Pharmacogenomics|April 16, 2019
Cell-free DNA diagnostics: current and emerging applications in oncologyPenn Muluhngwi, Roland Valdes, Rafael Fernandez-Botran, et al.
Pharmacogenomics|April 26, 2022
Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in ChinaWenpei Liu, Lihuan Lu, Hongqiu Pan, et al.
Pharmacogenomics|March 21, 2022
Parental understanding and attitudes following pharmacogenomic testing for pediatric neuropsychiatric patientsCourtney Berrios, Sophia K Sadaro, Tracy Sandritter, et al.
Pageof 276